Fred Alger Management’s Xenon Pharmaceuticals XENE Stock Holding History

Fred Alger Management’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-45,143	Closed	-$1.63M	–	573
2022 Q3	$1.63M	Buy	+45,143	New	+$1.62M	0.01%	353
2021 Q4	–	Sell	-105,989	Closed	-$1.62M	–	562
2021 Q3	$1.62M	Buy	+105,989	New	+$1.84M	﹤0.01%	356

Other funds holding XENE

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fred Alger Management's XENE Position: Q4 2022 in Review

Fred Alger Management sold out of Xenon Pharmaceuticals (XENE) in Q4 2022, closing a stake of 45,143 shares — an estimated $1.63M sold.

Fred Alger Management first reported a position in XENE in Q3 2021 and held it in 2 quarters. The position peaked at $1.63M in Q3 2022. 159 funds tracked by Wall St. Rank hold XENE as of Q4 2022.

Fred Alger Management reported no remaining Xenon Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Fred Alger Management sold 45,143 Xenon Pharmaceuticals shares in Q4 2022, an estimated $1.63M.
Fred Alger Management first reported a position in Xenon Pharmaceuticals in Q3 2021 and held it in 2 quarters.
Fred Alger Management's Xenon Pharmaceuticals position peaked at $1.63M in Q3 2022.
159 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q4 2022.

Based on Fred Alger Management's 13F filing for Q4 2022, filed 14 Feb 2023.